Skip to main content
. Author manuscript; available in PMC: 2009 Oct 29.
Published in final edited form as: Drug Alcohol Depend. 2008 Sep 20;99(1-3):28–36. doi: 10.1016/j.drugalcdep.2008.06.016

Figure 1. Interaction between Medication Type, Withdrawal Severity, and Attendance Outcome.

Figure 1

Interaction between medication type and withdrawal symptoms. Compared to clonidine, subjects on buprenorphine-naloxone had more days of treatment abstinence regardless of baseline COWS severity. For the clonidine group, individuals with low withdrawal symptoms had more days of treatment abstinence than those with high withdrawal symptoms.